Startups channel feed – Endpoints News

Startups channel feed

Decibel Therapeutics raises $82M as Laurence Reid looks to steer gene therapy pivot

5 years ago

What do the top 10 biotech M&A deals of 2020 tell us? Premiums are in, bolt-ons rule and the ADC comeback is on

5 years ago

Flagship launches Senda Biosciences with $88M in backing, looking to pioneer the field of 'Intersystems Biology'

5 years ago

Arena's Amit Munshi spins out his neuro sub into a biotech startup, with $56M for the baptism

5 years ago

Can B cells break the boundaries of cell therapy? Longwood startup has $52M to prove a new engineering tech

5 years ago

Pfizer scoops up an antibiotic in rare M&A deal, bagging a virtual startup operating on a shoestring budget

5 years ago

Bo Cumbo jumps from the top commercial post at Sarepta to the helm of a gene therapy startup with some influential backers, big plans and $107M

5 years ago

A long-haul biotech with some impressive backers and big goals recruits a major league R&D exec to the helm. What’s next?

5 years ago

Novartis bet $6B on the idea — now Versant, venBio have $45M to birth a platform play for radiopharmaceuticals

5 years ago

Venrock takes the wrap off its first microbiome startup, armed with $50M, a CEO from 23andMe and two founders from Stanford

5 years ago

The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased

5 years ago

The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn't going to stop them

5 years ago

A pharma exec gets $100M to chase a cancer-fighting idea uncovered in a 2017 Novartis study

5 years ago

With a $4M federal grant, Lumen jumps into the Covid-19 treatment race

5 years ago

Flagship's next big technological bet? The cloud

5 years ago

With $29M in Series A, Boehringer-backed Libra looks to tackle neurodegeneration through cellular cleaning

5 years ago

Immetas Therapeutics nabs $11M Series A to narrow their bispecific work targeting inflammation in age-related diseases

5 years ago

Can a magnetic cell therapy replace corneal transplantation? As eight-year journey leads to the clinic, two brothers unveil bold vision

5 years ago

Lava breaks prolonged silence with an $83M Series C and two I/O programs set for the clinic

5 years ago

Versant teams up with Stanford gene editing experts on a $45M next-gen play — marrying CRISPR and AAV to fix sickle cell

5 years ago

Arie Belldegrun and David Chang godfather the $110M launch of a new cell therapy player. And this one is also thinking big

5 years ago

Exclusive: Ginkgo teams with unknown upstart in hunt for Covid-19 antibody

5 years ago

FL56+FL57= infinite possibilities? Flagship's hybrid startup takes machine learning in drug discovery to the next level — and Covid-19 offers a quick test

5 years ago

New targeted therapy approaches win Rain Therapeutics $63M — designed to beat a quick path to approval

5 years ago

First page Previous page 49 50 515253 54 55 Next page Last page